🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you Dermsquared for featuring this work on Chronic Pruritus. We will have plenty of more content coming out about chronic pruritus! dermsquared.com/videos/topical…

Loved giving Grand Rounds at UCLA Health UCLA Dermatology this week. We talked about "Chronic Pruritus: reframing a historic symptom in a new therapeutic era" A storied group continues to rise. April Armstrong, MD MPH FAAD is building something really special.

How common are older patients in dermatology? Over 40% of patients in derm clinics are >65. The wave isnt coming, it's here.

IL-31 becomes an option. Exciting to have another target for so many pruritic patients with PN. galderma.com/news/galderma-…

Dr. John Barbeiri (John Barbieri, MD, MBA) has made significant contributions to dermatology, especially regarding the recent benzene issue. His efforts in engaging both experts and the public on this critical topic have been truly impactful. Let's honor his outstanding work by

Agree John Barbieri, MD, MBA is a special talent. Engaging and practical. A gift to the derm community.

When will JAK inhibitors replace steroids for short-term control of inflammatory disease? I imagine it's just an issue with access and cost? Thoughts?

3 out of every 10 USMD students applying to dermatology didn’t match. And this is a field where you need 15+ publications just to get an interview. Brutal.

Curious what Derms think about these numbers.

Especially noteworthy since the two main authors come from UAZ Medicine - Phoenix UA College of Medicine – Tucson where there is no PM&R program. Cudos to them for exploring this topic! Milan Oxspring, MD Riley Barnes MS #beardown

All credit for this project goes to Jaya Manjunath and our Geriatric Dermatology ERG AAD Jaya is a 4th year and a world leader in Geriatric Dermatology. We hope this provides practical tips to approach tough conversations that NEED to happen. The Dermatologist

Exciting to see innovation for diseases of older populations in dermatology. It’s about time. Efficacy and safety of low-dose Interleukin-2 in the treatment of moderate to severe bullous pemphigoid: jaad.org/article/S0190-…

Atopic Dermatitis therapeutics are moving fast! Recent developments: - New IL13 on the market with lebrikizumab's FDA approval - Tralokinumab autoinjector now available, decreasing the number of injections by 50% These are all benefits for our patients.

#asthma is a combination of #eczema and #urticaria of the airway #COPD is #prurigo #nodularis of the airway

Residency application season has officially begun. For those in leadership, remember to look for potential. We tend to tag trainees as "good" or "not good" and subsequently differentiate and project their career. Don't project a future; coach it.

BIG NEWS! The Allen Discovery Center for Neuroimmune Interactions with Cell Symposia will co-host the next Neuro-immune axis symposium on September 7-9, 2025 in NYC! Keynotes include The Nobel Prize recipient David Julius and Salk Institute Kaechlab (Sue Kaech). cell-symposia.com/neuroimmunolog…

I was thrilled to join PALTtalk with Caring to discuss an important, yet often overlooked issue: chronic itch in older adults. It's a condition that deserves more attention, and I’m excited to help shed light on it. Listen now: paltmed.org/podcast

Join us tomorrow. Updates on the current state of "aging skin" clinical care and research with clinical cases. Send me a message if interested.

Menopause and Eczema Menopause is an excellent example of how age influences the skin via multiple systems. Thanks to the National Eczema Association for highlighting this critical population. nationaleczema.org/blog/menopause…

Test Your Knowledge, Team Trivia Starts Tomorrow! Join us for an interactive symposium on IL-13 inhibitors in #atopicdermatitis, with National Eczema. Compete in real-time case discussions & expert panels, Dr. Shawn Kwatra and Daniel Butler MD bit.ly/4gHsadi